Allograft Inflammatory Factor 1 (AIF1) Antibody (Biotin)

Este producto es parte de AIF1 - Allograft inflammatory factor 1 like
Product Graph
416€ (200 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Allograft Inflammatory Factor 1 (AIF1) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx274640
tested applications
WB, IHC, IF/ICC

Description

Allograft Inflammatory Factor 1 (AIF1) Antibody (Biotin) is a Mouse Monoclonal antibody conjugated to Biotin against Allograft Inflammatory Factor 1 (AIF1).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Allograft Inflammatory Factor 1 (AIF1)
Host
Mouse
Reactivity
Rat
Recommended Dilution
WB: 0.5-5 µg/ml, IHC: 5-30 µg/ml, IF/ICC: 5-30 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Biotin
Isotype
IgG
Purification
Purified by Protein A and Protein G affinity chromatography.
Size 1
200 µl
Size 2
1 ml
Form
Liquid
Tested Applications
WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P55009
Gene ID
29427
Alias
AIF-1,IBA1,IRT-1,IRT1
Background
Antibody anti-AIF1
Status
RUO

Descripción

AIF1 is an inflammation-responsive protein primarily expressed in macrophages, microglia, and other immune cells. It plays a critical role in immune regulation, particularly in modulating inflammatory responses, cell migration, and phagocytosis. Structurally, AIF1 contains EF-hand calcium-binding motifs, enabling it to respond to changes in intracellular calcium levels, which are key to immune cell activation and signaling. AIF1 is upregulated during inflammatory diseases such as autoimmune disorders, transplant rejection, and atherosclerosis, where it contributes to immune cell recruitment and tissue remodeling. It is also involved in promoting macrophage activation and migration to sites of injury or infection. Dysregulated AIF1 expression is associated with chronic inflammation, cancer progression, and neuroinflammatory diseases like multiple sclerosis, making it a potential biomarker and therapeutic target for inflammatory and immune-related disorders.

Related Products

EH1425

Human AIF1(Allograft inflammatory factor 1) ELISA Kit

Ver Producto
ER1595

Rat AIF-1(Allograft inflammatory factor 1) ELISA Kit

Ver Producto
FNab09944

anti- AIF1 antibody

AIF1, also named as G1, IBA1 or daintain/AIF-1, is a 143 amino acid cytoplasmic, inflammation response scaffold protein. It is constitutively expressed in monocytes and macrophages and is known to be involved in macrophage activation. It is a marker of activated macrophage. Despite a lack of detailed knowledge on the in vivo physiological functions of AIF-1, there is growing evidence that shows its aberrant expression contributes to the pathogenesis of many autoimmune diseases, including rheumatoid arthritis. (20944424). AIF1 is an actin-binding protein that enhances membrane ruffling and RAC activation. It enhances lymphocyte migration and the actin-bundling activity of LCP1. AIF1 plays a role in RAC signaling and in phagocytosis and a role in vascular inflammation. AIF1 promotes the proliferation of vascular smooth muscle cells and of T-lymphocytes. It is also as a microglial cell marker.

Ver Producto